Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes

Journal of Biological Chemistry

Volumn 287, Issue 25, 2012, Pages 21303-21315

  Villota, Claudio ^a,b,c   Campos, América ^a,b,c   Vidaurre, Soledad ^a,b,c   Oliveira Cruz, Luciana ^a,b   Boccardo, Enrique ^d,e   Burzio, Verónica A ^a,b,c   Varas, Manuel ^a,b,c   Villegas, Jaime ^a,b,c   Villa, Luisa L ^d   Valenzuela, Pablo D T ^a,b   Socías, Miguel ^f   Roberts, Sally ^g   Burzio, Luis O ^a,b,c  

^a Andes Biotechnologies SA   (Chile)

^b Fundacion Ciencia para la Vida   (Chile)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSIDAD DEL DESARROLLO   (Chile)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE; CANCER CELLS; CANCER PROGRESSION; CELLULAR FACTORS; CELLULAR PATHWAY; CERVICAL CANCERS; DIFFERENTIAL EXPRESSIONS; DOWN-REGULATION; ETIOLOGICAL AGENT; HUMAN KERATINOCYTES; HUMAN PAPILLOMAVIRUS; IMMORTALIZED CELLS; NON-CODING RNAS; ONCOGENESIS;

CELL PROLIFERATION; CELLS; RNA;

ONCOGENIC VIRUSES;

COMPLEMENTARY RNA; MITOCHONDRIAL RNA; PROTEIN E6; PROTEIN E7; SHORT HAIRPIN RNA; UNTRANSLATED RNA;

AMPLICON; ARTICLE; CANCER RISK; CELL CYCLE REGULATION; CONTROLLED STUDY; DOWN REGULATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS ONCOGENE; VIRUS PARTICLE; WART VIRUS;

CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; RNA; RNA, ANTISENSE; RNA, UNTRANSLATED;

EID: 84862282201     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.326694     Document Type: Article

References (68)

1. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer. The next generation. Cell 144, 646-674
2. D'Agostino, D. M., Bernardi, P., Chieco-Bianchi, L., and Ciminale, V. (2005) Mitochondria as functional targets of proteins coded by human tumor viruses. Adv. Cancer Res. 94, 87-142 (Pubitemid 41202365)
3. McLaughlin-Drubin, M. E., and Munger, K. (2008) Viruses associated with human cancer. Biochim. Biophys. Acta 1782, 127-150
4. McLaughlin-Drubin, M. E., and Münger, K. (2009) Oncogenic activities of human papillomaviruses. Virus Res. 143, 195-208
5. zur Hausen, H. (2009) Papillomaviruses in the causation of human cancers. A brief historical account. Virology 384, 260-265
6. zur Hausen, H. (2002) Papillomaviruses and cancer. From basic studies to clinical application. Nat. Rev. Cancer 2, 342-350
7. Kroemer, G. (2006) Mitochondria in cancer. Oncogene 25, 4630-4632
8. Chatterjee, A., Dasgupta, S., and Sidransky, D. (2011) Mitochondrial subversion in cancer. Cancer Prev. Res. 4, 638-654
9. Villegas, J., Burzio, V., Villota, C., Landerer, E., Martinez, R., Santander, M., Martinez, R., Pinto, R., Vera, M. I., Boccardo, E., Villa, L. L., and Burzio, L. O. (2007) Expression of a novel non-coding mitochondrial RNA in human proliferating cells. Nucleic Acids Res. 35, 7336-7347
10. Burzio, V. A., Villota, C., Villegas, J., Landerer, E., Boccardo, E., Villa, L. L., Martínez, R., Lopez, C., Gaete, F., Toro, V., Rodriguez, X., and Burzio, L. O. (2009) Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells. Proc. Natl. Acad. Sci. U.S.A. 106, 9430-9434
11. 0-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 24, 4883-4893
12. Sligh, J. E., Levy, S. E., Waymire, K. G., Allard, P., Dillehay, D. L., Nusinowitz, S., Heckenlively, J. R., MacGregor, G. R., and Wallace, D. C. (2000) Maternal germ line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice. Proc. Natl. Acad. Sci. U.S.A. 97, 14461-14466 (Pubitemid 32016598)
13. Landerer, L., Villegas, J., Burzio, V. A., Oliveira, L., Villota, C., Lopez, C., Restovic, F., Martinez, R., Castillo, O., and Burzio, L. O. (2011) Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells. Cell Oncol. 34, 297-305
14. Barbosa, M. S., and Schlegel, R. (1989) The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4, 1529-1532 (Pubitemid 20008936)
15. Romanczuk, H., Villa, L. L., Schlegel, R., and Howley, P. M. (1991) The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J. Virol. 62, 2739-2744
16. Halbert, C. L., Demers, G. W., and Galloway, D. A. (1991) The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65, 473-478
17. Boccardo, E., Manzini Baldi, C. V., Carvalho, A. F., Rabachini, T., Torres, C., Barreta, L. A., Brentani, H., and Villa, L. L. (2010) Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-α. Carcinogenesis 31, 521-531
18. Young, P. G., and Attardi, G. (1975) Characterization of double-stranded RNA from HeLa cell mitochondria. Biochem. Biophys. Res. Commun. 65, 1201-1207
19. Gaines, G., and Attardi, G. (1984) Highly efficient RNA-synthesizing system that uses isolated human mitochondria. New initiation events and in vivo-like processing patterns. Mol. Cell Biol. 4, 1605-1617 (Pubitemid 15131922)
20. Kruse, B., Murdter, N. N., and Attardi, G. (1995) Transcription system using a HeLa cell mitochondrial lysate. Methods Mol. Biol. 37, 179-197
21. Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., Gertler, F. B., Scott, M. L., and Van Parijs, L. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406 (Pubitemid 36278858)
22. 2/M cell cycle arrest of keratinocytes but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. Virology 412, 196-210
23. Alvarez-Salas, L. M., Benítez-Hess, M. L., and DiPaolo, J. A. (2003) Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses. Antivir. Ther. 8, 265-278 (Pubitemid 37101629)
24. Raj, K., Berguerand, S., Southern, S., Doorbar, J., and Beard, P. (2004) E1 empty set E4 protein of human papillomavirus type 16 associates with mitochondria. J. Virol. 78, 7199-7207 (Pubitemid 38781558)
25. Doorbar, J., Ely, S., Sterling, J., McLean, C., and Crawford, L. (1991) Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352, 824-827 (Pubitemid 21912441)
26. Mattick, J. S., and Makunin, I. V. (2006) Non-coding RNA. Hum. Mol. Genet. 15, R17-R29
27. Esquela-Kerscher, A., and Slack, F. J. (2006) Oncomirs. MicroRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269
28. Lee, S. K., and Calin, G. A. (2011) Non-coding RNAs and cancer. New paradigms in oncology. Discov. Med. 11, 245-254
29. Payne, S. R., and Kemp, C. J. (2005) Tumor suppressor genetics. Carcinogenesis 26, 2031-2045 (Pubitemid 41672190)
30. Bernard, B. A., Bailly, C., Lenoir, M. C., Darmon, M., Thierry, F., and Yaniv, M. (1989) The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol. 63, 4317-4324 (Pubitemid 19229429)
31. Romanczuk, H., Thierry, F., and Howley, P. M. (1990) Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64, 2849-2859 (Pubitemid 20171275)
32. Steger, G., and Corbach, S. (1997) Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71, 50-58 (Pubitemid 26412264)
33. Smith, J. A., White, E. A., Sowa, M. E., Powell, M. L., Ottinger, M., Harper, J. W., and Howley, P. M. (2010) Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl. Acad. Sci. U.S.A. 107, 3752-3757
34. Ramírez-Salazar, E., Centeno, F., Nieto, K., Valencia- Hernández, A., Salcedo, M., and Garrido, E. (2011) HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation, and cell differentiation. Virol. J. 8, 247-256
35. Lee, D., Kim, H. Z., Jeong, K. W., Shim, Y. S., Horikawa, I., Barrett, J. C., and Choe, J. (2002) Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter. J. Biol. Chem. 277, 27748-27756 (Pubitemid 34966719)
36. McBride, A. A., Oliveira, J. G., and McPhillips, M. G. (2006) Partitioning viral genomes in mitosis. Same idea, different targets. Cell Cycle 5, 1499-1502 (Pubitemid 44091967)
37. Lee, A. Y., and Chiang, C. M. (2009) Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability. J. Biol. Chem. 284, 2778-2786
38. McBride, A. A., Romanczuk, H., and Howley, P. M. (1991) The papillomavirus E2 regulatory proteins. J. Biol. Chem. 266, 18411-18414 (Pubitemid 21908095)
39. Webster, K., Parish, J., Pandya, M., Stern, P. L., Clarke, A. R., and Gaston, K. (2000) The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J. Biol. Chem. 275, 87-94 (Pubitemid 30038957)
40. Bellanger, S., Tan, C. L., Xue, Y. Z., Teissier, S., and Thierry, F. (2011) Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. Am. J. Cancer Res. 1, 373-389
41. Pfefferle, R., Marcuzzi, G. P., Akgül, B., Kasper, H. U., Schulze, F., Haase, I., Wickenhauser, C., and Pfister, H. (2008) The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J. Invest. Dermatol. 128, 2310-2315
42. Hufbauer, M., Lazić, D., Akgül, B., Brandsma, J. L., Pfister, H., and Weissenborn, S. J. (2010) Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice. Virology 403, 128-136
43. Leykauf, K., Kabsch, K., Gassler, N., Gissmann, L., Alonso, A., and Schenkel, J. (2008) Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern. Transgenic Res. 17, 1-8
44. Lin, K. Y., Guarnieri, F. G., Staveley-O'Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., and Wu, T. C. (1996) Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56, 21-26 (Pubitemid 26010379)
45. Blachon, S., Bellanger, S., Demeret, C., and Thierry F. (2005) Nucleocytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis. J. Biol. Chem. 280, 36088-36098 (Pubitemid 41633880)
46. Liu, Q., and Paroo, Z. (2010) Biochemical principles of small RNA pathways. Annu. Rev. Biochem. 79, 295-319
47. Chen, L. L., and Carmichael, G. G. (2010) Decoding the function of nuclear long non-coding RNAs. Curr. Opin. Cell Biol. 22, 357-364
48. Wang, Q., and Carmichael, G. G. (2004) Effects of length and location on the cellular response to double-stranded RNA. Microbiol. Mol. Biol. Rev. 68, 432-452 (Pubitemid 39238277)
49. Wahid, A. M., Coventry, V. K., and Conn, G. L. (2008) Systematic deletion of the adenovirus-associated RNAI terminal stem reveals a surprisingly active RNA inhibitor of double-stranded RNA-activated protein kinase. J. Biol. Chem. 283, 17485-17493
50. Hellwig, S., and Bass, B. L. (2008) A starvation-induced noncoding RNA modulates expression of Dicer-regulated genes. Proc. Natl. Acad. Sci. U.S.A. 105, 12897-12902
51. Hawley-Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., and Schiller, J. T. (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8, 3905-3910 (Pubitemid 20016074)
52. Gewin, L., and Galloway, D. A. (2001) E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol. 75, 7198-7201 (Pubitemid 32641609)
53. Helt, A. M., and Galloway, D. A. (2001) Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J. Virol. 75, 6737-6747
54. Liu, X., Roberts, J., Dakic, A., Zhang, Y., and Schlegel, R. (2008) HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function. Virology 375, 611-623
55. Villegas, J., Müller, I., Arredondo, J., Pinto, R., and Burzio, L. O. (2002) A putative RNA editing from U to C in a mouse mitochondrial transcript. Nucleic Acids Res. 30, 1895-1901 (Pubitemid 34537583)
56. Simpson, L., Aphasizhev, R., Gao, G., and Kang, X. (2004) Mitochondrial proteins and complexes in Leishmania and Trypanosoma involved in U-insertion/deletion RNA editing. RNA 10, 159-170 (Pubitemid 38129820)
57. Rogers, K., Gao, G., and Simpson, L. (2007) Uridylate-specific 3′ 5′-exoribonucleases involved in uridylate-deletion RNA editing in trypanosomatid mitochondria. J. Biol. Chem. 282, 29073-29080 (Pubitemid 350043348)
58. Kapushoc, S. T., and Simpson, L. (1999) In vitro uridine insertion RNA editing mediated by cis-acting guide RNAs. RNA 5, 656-669 (Pubitemid 29218456)
59. Nakahara, T., and Lambert, P. F. (2007) Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus. Virology 366, 316-329 (Pubitemid 47391000)
60. Lallemand-Breitenbach, V., and de Thé, H. (2010) PML nuclear bodies. Cold Spring Harb. Perspect. Biol. 2, a000661
61. Guccione, E., Lethbridge, K. J., Killick, N., Leppard, K. N., and Banks, L. (2004) HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures. Oncogene 23, 4662-4672 (Pubitemid 38859455)
62. Swindle, C. S., Zou, N., Van Tine, B. A., Shaw, G. M., Engler, J. A., and Chow, L. T. (1999) Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol. 73, 1001-1009 (Pubitemid 29036751)
63. Bischof, O., Nacerddine, K., and Dejean, A. (2005) Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol. Cell Biol. 25, 1013-1024 (Pubitemid 40165809)
64. Ebert, M. S., and Sharp, P. A. (2010) MicroRNA sponges. Progress and possibilities. RNA 16, 2043-2050
65. Salmena, L., Poliseno, L., Tay, Y., Kats, L., and Pandolfi, P. P. (2011) A ceRNA hypothesis. The Rosetta Stone of a hidden RNA language? Cell 146, 353-358
66. Cazalla, D., Yario, T., and Steitz, J. A. (2010) Down-regulation of a host microRNA by a herpesvirus saimiri noncoding RNA. Science 328, 1563-1566
67. Xue, Y., Bellanger, S., Zhang, W., Lim, D., Low, J., Lunny, D., and Thierry, F. (2010) HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res. 70, 5316-5325'
68. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA target. Cell 120, 15-20 (Pubitemid 40094598)